Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 526

1.

Acute kidney injury: an unusual complication of posaconazole use.

Otu A, Bongomin F, Kosmidis C, Denning DW.

J Chemother. 2018 Oct - Dec;30(6-8):380-383. doi: 10.1080/1120009X.2018.1522472.

PMID:
30663547
2.

Therapeutic drug monitoring and adverse events of delayed-release posaconazole tablets in patients with chronic pulmonary aspergillosis.

Kosmidis C, Rodriguez-Goncer I, Rautemaa-Richardson R, Richardson MD, Moore CB, Denning DW.

J Antimicrob Chemother. 2018 Dec 26. doi: 10.1093/jac/dky539. [Epub ahead of print]

PMID:
30590533
3.

Chronic pulmonary aspergillosis following pulmonary embolism.

Tunney R, Rodger K, Denning DW, Kosmidis C.

Med Mycol Case Rep. 2018 Nov 9;23:20-22. doi: 10.1016/j.mmcr.2018.11.002. eCollection 2019 Mar.

4.

Inducible Cell Fusion Permits Use of Competitive Fitness Profiling in the Human Pathogenic Fungus Aspergillus fumigatus.

Macdonald D, Thomson DD, Johns A, Contreras Valenzuela A, Gilsenan JM, Lord KM, Bowyer P, Denning DW, Read ND, Bromley MJ.

Antimicrob Agents Chemother. 2018 Dec 21;63(1). pii: e01615-18. doi: 10.1128/AAC.01615-18. Print 2019 Jan.

PMID:
30397071
5.

Histoplasma capsulatum antigen detection tests as an essential diagnostic tool for patients with advanced HIV disease in low and middle income countries: A systematic review of diagnostic accuracy studies.

Nacher M, Blanchet D, Bongomin F, Chakrabarti A, Couppié P, Demar M, Denning DW, Djossou F, Epelboin L, Govender N, Leitão T, Mac Donald S, Mandengue C, Marques da Silva SH, Oladele R, Panizo MM, Pasqualotto A, Ramos R, Swaminathan S, Rodriguez-Tudela JL, Vreden S, Zancopé-Oliveira R, Adenis A.

PLoS Negl Trop Dis. 2018 Oct 19;12(10):e0006802. doi: 10.1371/journal.pntd.0006802. eCollection 2018 Oct.

6.

Pulmonary cryptococcosis: A review of pathobiology and clinical aspects.

Setianingrum F, Rautemaa-Richardson R, Denning DW.

Med Mycol. 2019 Feb 1;57(2):133-150. doi: 10.1093/mmy/myy086.

PMID:
30329097
7.

Nebulised N-Acetylcysteine for Unresponsive Bronchial Obstruction in Allergic Brochopulmonary Aspergillosis: A Case Series and Review of the Literature.

Otu A, Langridge P, Denning DW.

J Fungi (Basel). 2018 Oct 15;4(4). pii: E117. doi: 10.3390/jof4040117. Review.

8.

Micafungin may be safely administered as outpatient parenteral antimicrobial therapy for chronic pulmonary aspergillosis.

Otu AA, Bongomin F, Bazaz R, Harris C, Denning DW, Kosmidis C.

Mycoses. 2018 Sep 29. doi: 10.1111/myc.12857. [Epub ahead of print]

PMID:
30267594
9.

Pathophysiological aspects of Aspergillus colonization in disease.

Gago S, Denning DW, Bowyer P.

Med Mycol. 2018 Sep 15. doi: 10.1093/mmy/myy076. [Epub ahead of print]

PMID:
30239804
10.

Lung colonization by Aspergillus fumigatus is controlled by ZNF77.

Gago S, Overton NLD, Ben-Ghazzi N, Novak-Frazer L, Read ND, Denning DW, Bowyer P.

Nat Commun. 2018 Sep 20;9(1):3835. doi: 10.1038/s41467-018-06148-7.

11.

The role of medical mycology societies in combating invasive fungal infections in low- and middle-income countries: A Nigerian model.

Oladele RO, Osaigbovo II, Ayanlowo OO, Otu AA, Hoenigl M, Cornely OA, Chakrabarti A, Denning DW.

Mycoses. 2019 Jan;62(1):16-21. doi: 10.1111/myc.12845. Epub 2018 Oct 8. Review.

PMID:
30184285
12.

Estimated burden of serious human fungal diseases in Turkey.

Hilmioğlu-Polat S, Seyedmousavi S, Ilkit M, Hedayati MT, Inci R, Tumbay E, Denning DW.

Mycoses. 2019 Jan;62(1):22-31. doi: 10.1111/myc.12842. Epub 2018 Sep 21.

PMID:
30107069
13.

Global burden of recurrent vulvovaginal candidiasis: a systematic review.

Denning DW, Kneale M, Sobel JD, Rautemaa-Richardson R.

Lancet Infect Dis. 2018 Nov;18(11):e339-e347. doi: 10.1016/S1473-3099(18)30103-8. Epub 2018 Aug 2. Review.

PMID:
30078662
14.

Case Definition of Chronic Pulmonary Aspergillosis in Resource-Constrained Settings.

Denning DW, Page ID, Chakaya J, Jabeen K, Jude CM, Cornet M, Alastruey-Izquierdo A, Bongomin F, Bowyer P, Chakrabarti A, Gago S, Guto J, Hochhegger B, Hoenigl M, Irfan M, Irurhe N, Izumikawa K, Kirenga B, Manduku V, Moazam S, Oladele RO, Richardson MD, Tudela JLR, Rozaliyani A, Salzer HJF, Sawyer R, Simukulwa NF, Skrahina A, Sriruttan C, Setianingrum F, Wilopo BAP, Cole DC, Getahun H.

Emerg Infect Dis. 2018 Aug;24(8). doi: 10.3201/eid2408.171312.

15.

Estimated Burden of Serious Fungal Diseases in Serbia.

Arsenijević VA, Denning DW.

J Fungi (Basel). 2018 Jun 25;4(3). pii: E76. doi: 10.3390/jof4030076.

16.

Estimated Burden of Serious Fungal Infections in Mozambique.

Sacarlal J, Denning DW.

J Fungi (Basel). 2018 Jun 23;4(3). pii: E75. doi: 10.3390/jof4030075.

17.

Assessment of posaconazole salvage therapy in chronic pulmonary aspergillosis using predefined response criteria.

Rodriguez-Goncer I, Harris C, Kosmidis C, Muldoon EG, Newton PJ, Denning DW.

Int J Antimicrob Agents. 2018 Aug;52(2):258-264. doi: 10.1016/j.ijantimicag.2018.06.001. Epub 2018 Jun 12.

PMID:
29906567
18.

Estimated Burden of Serious Fungal Infections in Malawi.

Kalua K, Zimba B, Denning DW.

J Fungi (Basel). 2018 May 21;4(2). pii: E61. doi: 10.3390/jof4020061.

19.

Siemens Immulite Aspergillus-specific IgG assay for chronic pulmonary aspergillosis diagnosis.

Page ID, Richardson MD, Denning DW.

Med Mycol. 2018 May 14. doi: 10.1093/mmy/myy024. [Epub ahead of print]

PMID:
29762749
20.

Prior subclinical histoplasmosis revealed in Nigeria using histoplasmin skin testing.

Oladele RO, Toriello C, Ogunsola FT, Ayanlowo OO, Foden P, Fayemiwo AS, Osaigbovo II, Iwuafor AA, Shettima S, Ekundayo HA, Richardson MD, Denning DW.

PLoS One. 2018 May 9;13(5):e0196224. doi: 10.1371/journal.pone.0196224. eCollection 2018.

21.

Burden of Serious Fungal Infections in Argentina.

Riera FO, Caeiro JP, Denning DW.

J Fungi (Basel). 2018 Apr 24;4(2). pii: E51. doi: 10.3390/jof4020051.

22.

Twelve-month clinical outcomes of 206 patients with chronic pulmonary aspergillosis.

Bongomin F, Harris C, Hayes G, Kosmidis C, Denning DW.

PLoS One. 2018 Apr 10;13(4):e0193732. doi: 10.1371/journal.pone.0193732. eCollection 2018.

23.

The Burden of Serious Fungal Infections in Cameroon.

Mandengue CE, Denning DW.

J Fungi (Basel). 2018 Mar 30;4(2). pii: E44. doi: 10.3390/jof4020044.

24.

Estimation of the Burden of Serious Human Fungal Infections in Malaysia.

Velayuthan RD, Samudi C, Lakhbeer Singh HK, Ng KP, Shankar EM, Denning DW.

J Fungi (Basel). 2018 Mar 19;4(1). pii: E38. doi: 10.3390/jof4010038.

25.

Estimating the Burden of Serious Fungal Infections in Uruguay.

Macedo-Viñas M, Denning DW.

J Fungi (Basel). 2018 Mar 18;4(1). pii: E37. doi: 10.3390/jof4010037.

26.

Burden of Fungal Infections in Colombia.

Alvarez-Moreno CA, Cortes JA, Denning DW.

J Fungi (Basel). 2018 Mar 21;4(2). pii: E41. doi: 10.3390/jof4020041.

27.

Mutations in EEA1 are associated with allergic bronchopulmonary aspergillosis and affect phagocytosis of Aspergillus fumigatus by human macrophages.

Overton NLD, Brakhage AA, Thywißen A, Denning DW, Bowyer P.

PLoS One. 2018 Mar 16;13(3):e0185706. doi: 10.1371/journal.pone.0185706. eCollection 2018.

28.

Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline.

Ullmann AJ, Aguado JM, Arikan-Akdagli S, Denning DW, Groll AH, Lagrou K, Lass-Flörl C, Lewis RE, Munoz P, Verweij PE, Warris A, Ader F, Akova M, Arendrup MC, Barnes RA, Beigelman-Aubry C, Blot S, Bouza E, Brüggemann RJM, Buchheidt D, Cadranel J, Castagnola E, Chakrabarti A, Cuenca-Estrella M, Dimopoulos G, Fortun J, Gangneux JP, Garbino J, Heinz WJ, Herbrecht R, Heussel CP, Kibbler CC, Klimko N, Kullberg BJ, Lange C, Lehrnbecher T, Löffler J, Lortholary O, Maertens J, Marchetti O, Meis JF, Pagano L, Ribaud P, Richardson M, Roilides E, Ruhnke M, Sanguinetti M, Sheppard DC, Sinkó J, Skiada A, Vehreschild MJGT, Viscoli C, Cornely OA.

Clin Microbiol Infect. 2018 May;24 Suppl 1:e1-e38. doi: 10.1016/j.cmi.2018.01.002. Epub 2018 Mar 12.

PMID:
29544767
29.

Burden of Severe Fungal Infections in Burkina Faso.

Bamba S, Zida A, Sangaré I, Cissé M, Denning DW, Hennequin C.

J Fungi (Basel). 2018 Mar 11;4(1). pii: E35. doi: 10.3390/jof4010035.

30.

An Estimate of Severe and Chronic Fungal Diseases in the Republic of Kazakhstan.

Kemaykin VM, Tabinbaev NB, Khudaibergenova MS, Olifirovich AA, Abdrakhmanova LM, Denning DW, Klimko N.

J Fungi (Basel). 2018 Mar 8;4(1). pii: E34. doi: 10.3390/jof4010034.

31.

Diagnosis and Management of Pneumocystis Pneumonia in Resource-poor Settings.

Oladele RO, Otu AA, Richardson MD, Denning DW.

J Health Care Poor Underserved. 2018;29(1):107-158. doi: 10.1353/hpu.2018.0010.

PMID:
29503291
32.

The Burden of Fungal Diseases in Romania.

Mareș M, Moroti-Constantinescu VR, Denning DW.

J Fungi (Basel). 2018 Mar 1;4(1). pii: E31. doi: 10.3390/jof4010031.

33.

An Estimate of the Burden of Fungal Disease in Norway.

Nordøy I, Hesstvedt L, Torp Andersen C, Mylvaganam H, Kols NI, Falch BM, Tofteland S, Müller F, Denning DW.

J Fungi (Basel). 2018 Feb 21;4(1). pii: E29. doi: 10.3390/jof4010029.

34.

Receiver operating characteristic curve analysis of four Aspergillus-specific IgG assays for the diagnosis of chronic pulmonary aspergillosis.

Page ID, Baxter C, Hennequin C, Richardson MD, van Hoeyveld E, van Toorenenbergen AW, Denning DW.

Diagn Microbiol Infect Dis. 2018 May;91(1):47-51. doi: 10.1016/j.diagmicrobio.2018.01.001. Epub 2018 Jan 6.

PMID:
29398462
35.

HIV-Associated Cryptococcal Disease in Resource-Limited Settings: A Case for "Prevention Is Better Than Cure"?

Oladele RO, Bongomin F, Gago S, Denning DW.

J Fungi (Basel). 2017 Dec 2;3(4). pii: E67. doi: 10.3390/jof3040067. Review.

36.

Global and Multi-National Prevalence of Fungal Diseases-Estimate Precision.

Bongomin F, Gago S, Oladele RO, Denning DW.

J Fungi (Basel). 2017 Oct 18;3(4). pii: E57. doi: 10.3390/jof3040057. Review.

37.

Innate and Adaptive Immune Defects in Chronic Pulmonary Aspergillosis.

Bongomin F, Harris C, Foden P, Kosmidis C, Denning DW.

J Fungi (Basel). 2017 May 29;3(2). pii: E26. doi: 10.3390/jof3020026.

38.

Burden of Serious Fungal Infections in Jordan.

Wadi J, Denning DW.

J Fungi (Basel). 2018 Jan 18;4(1). pii: E15. doi: 10.3390/jof4010015.

39.

Anti-Aspergillus Activities of the Respiratory Epithelium in Health and Disease.

Bertuzzi M, Hayes GE, Icheoku UJ, van Rhijn N, Denning DW, Osherov N, Bignell EM.

J Fungi (Basel). 2018 Jan 8;4(1). pii: E8. doi: 10.3390/jof4010008. Review.

40.

Subacute Invasive Aspergillosis Associated With Sorafenib Therapy for Hepatocellular Carcinoma.

Bazaz R, Denning DW.

Clin Infect Dis. 2018 Jun 18;67(1):156-157. doi: 10.1093/cid/ciy038. No abstract available.

PMID:
29370392
41.

Histoplasmosis in Africa: An emerging or a neglected disease?

Oladele RO, Ayanlowo OO, Richardson MD, Denning DW.

PLoS Negl Trop Dis. 2018 Jan 18;12(1):e0006046. doi: 10.1371/journal.pntd.0006046. eCollection 2018 Jan. Review.

42.

The Management of Chronic Pulmonary Aspergillosis: The UK National Aspergillosis Centre Approach.

Maghrabi F, Denning DW.

Curr Fungal Infect Rep. 2017;11(4):242-251. doi: 10.1007/s12281-017-0304-7. Epub 2017 Nov 13. Review.

43.

Elevated Aspergillus-specific antibody levels among HIV infected Ugandans with pulmonary tuberculosis.

Kwizera R, Parkes-Ratanshi R, Page ID, Sekaggya-Wiltshire C, Musaazi J, Fehr J, Castelnuovo B, Kambugu A, Denning DW.

BMC Pulm Med. 2017 Nov 21;17(1):149. doi: 10.1186/s12890-017-0500-9.

44.

A Review of Onychomycosis Due to Aspergillus Species.

Bongomin F, Batac CR, Richardson MD, Denning DW.

Mycopathologia. 2018 Jun;183(3):485-493. doi: 10.1007/s11046-017-0222-9. Epub 2017 Nov 16. Review.

45.

Corticosteroid treatment is associated with increased filamentous fungal burden in allergic fungal disease.

Fraczek MG, Chishimba L, Niven RM, Bromley M, Simpson A, Smyth L, Denning DW, Bowyer P.

J Allergy Clin Immunol. 2018 Aug;142(2):407-414. doi: 10.1016/j.jaci.2017.09.039. Epub 2017 Nov 6.

PMID:
29122659
46.

An investigation of antifungal stewardship programmes in England.

Micallef C, Ashiru-Oredope D, Hansraj S, Denning DW, Agrawal SG, Manuel RJ, Schelenz S, Guy R, Muller-Pebody B, Patel R, Howard P, Hopkins S, Johnson E, Enoch DA.

J Med Microbiol. 2017 Nov;66(11):1581-1589. doi: 10.1099/jmm.0.000612. Epub 2017 Oct 25.

47.

F508del CFTR gene mutation in patients with allergic bronchopulmonary aspergillosis.

Gamaletsou MN, Hayes G, Harris C, Brock J, Muldoon EG, Denning DW.

J Asthma. 2018 Aug;55(8):837-843. doi: 10.1080/02770903.2017.1373808. Epub 2017 Oct 16.

PMID:
29035608
48.

Emergence of Echinocandin Resistance Due to a Point Mutation in the fks1 Gene of Aspergillus fumigatus in a Patient with Chronic Pulmonary Aspergillosis.

Jiménez-Ortigosa C, Moore C, Denning DW, Perlin DS.

Antimicrob Agents Chemother. 2017 Nov 22;61(12). pii: e01277-17. doi: 10.1128/AAC.01277-17. Print 2017 Dec.

49.

Future Research Priorities in Fungal Resistance.

McCarthy MW, Denning DW, Walsh TJ.

J Infect Dis. 2017 Aug 15;216(suppl_3):S484-S492. doi: 10.1093/infdis/jix103.

PMID:
28911040
50.

Tuberculosis/cryptococcosis co-infection in China between 1965 and 2016.

Fang W, Zhang L, Liu J, Denning DW, Hagen F, Jiang W, Hong N, Deng S, Lei X, Deng D, Liao W, Xu J, Boekhout T, Chen M, Pan W.

Emerg Microbes Infect. 2017 Aug 23;6(8):e73. doi: 10.1038/emi.2017.61. Review.

Supplemental Content

Loading ...
Support Center